ENTRY       D11930                      Drug
NAME        Betibeglogene autotemcel (USAN/INN);
            Zynteglo (TN)
PRODUCT     ZYNTEGLO (bluebird bio)
REMARK      ATC code: B06AX02
            Product: D11930<US>
EFFICACY    Hematologic disease therapeutic agent
  DISEASE   beta-Thalassemia [DS:H00228]
  TYPE      Cellular therapy product
COMMENT     Treatment of betathalassemia
TARGET      CD34 [HSA:947] [KO:K06474]
  PATHWAY   hsa04514(947)  Cell adhesion molecules
            hsa04640(947)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B06 OTHER HEMATOLOGICAL AGENTS
               B06A OTHER HEMATOLOGICAL AGENTS
                B06AX Other hematological agents
                 B06AX02 Betibeglogene autotemcel
                  D11930  Betibeglogene autotemcel (USAN/INN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD34
                 D11930  Betibeglogene autotemcel (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             Cellular and gene therapy products
              D11930
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11930
///
